Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.

Flory, A B; Rassnick, K M; Al-Sarraf, R; Bailey, D B; Balkman, C E; Kiselow, M A; Autio, K

Flory, A B; Rassnick, K M; Al-Sarraf, R; Bailey, D B; Balkman, C E; Kiselow, M A; Autio, K.

Affiliation

Flory AB; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

J Vet Intern Med ; 22(1): 164-71, 2008.

Article in En | MEDLINE | ID: mdl-18289305

Subject(s)

Antineoplastic Agents/therapeutic use; Dacarbazine/therapeutic use; Dog Diseases/drug therapy; Drug Resistance, Neoplasm/drug effects; Lomustine/therapeutic use; Lymphoma/veterinary; Animals; Antineoplastic Agents/adverse effects; Dacarbazine/adverse effects; Dogs; Dose-Response Relationship, Drug; Female; Lomustine/adverse effects; Lymphoma/drug therapy; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Dacarbazine / Dog Diseases / Lomustine / Lymphoma / Antineoplastic Agents Type of study: Guideline Limits: Animals Language: En Journal: J Vet Intern Med Journal subject: MEDICINA INTERNA / MEDICINA VETERINARIA Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google